NDC 72934-1027
BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8%
Brimonidine Tartrate 0.25% / Potassium Azeloyl Diglycinate 8%
BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Brimonidine Tartrate.
| Product ID | 72934-1027_88ef2cc1-1856-9606-e053-2995a90a2e67 |
| NDC | 72934-1027 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% |
| Generic Name | Brimonidine Tartrate 0.25% / Potassium Azeloyl Diglycinate 8% |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-05-16 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Sincerus Florida, LLC |
| Substance Name | BRIMONIDINE TARTRATE |
| Active Ingredient Strength | 0 g/100g |
| Pharm Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |